Efficacy and Tolerability of Peginterferon <i>α</i>-2a and Peginterferon <i>α</i>-2b, Both plus Ribavirin, for Chronic Hepatitis C: A Meta-Analysis of Randomized Controlled Trials

<table>SVR rates of chronic hepatitis C patients who received the two regimens of peginterferon <i>α</i>-2a and peginterferon <i>α</i>-2b, both plus ribavirin. </table>

Gastroenterology Research and Practice

fig2

Figure 2

Figure 2: Efficacy and Tolerability of Peginterferon <i>α</i>-2a and Peginterferon <i>α</i>-2b, Both plus Ribavirin, for Chronic Hepatitis C: A Meta-Analysis of Randomized Controlled Trials 

Figure 2 | Efficacy and Tolerability of Peginterferon α-2a and Peginterferon α-2b, Both plus Ribavirin, for Chronic Hepatitis C: A Meta-Analysis of Randomized Controlled Trials 